Literature DB >> 20003322

A replication study of the association between the IL12B promoter allele CTCTAA and susceptibility to cerebral malaria in Thai population.

Izumi Naka1, Jintana Patarapotikul, Katsushi Tokunaga, Hathairad Hananantachai, Naoyuki Tsuchiya, Jun Ohashi.   

Abstract

BACKGROUND: Interleukin-12 (IL-12), a heterodimeric cytokine composed of p35 and p40 subunits, has been thought to play an important role in the pathogenesis of malaria. The IL-12p40 subunit is encoded by the IL12B gene. An IL12B promoter allele, CTCTAA, at rs17860508 has been reported to be associated with susceptibility to cerebral malaria in African populations. However, this association has not so far been replicated in non-African populations.
METHODS: To examine whether the CTCTAA allele is associated with susceptibility to cerebral malaria in Asian populations, 303 Thai patients with Plasmodium falciparum malaria (109 cerebral malaria and 194 mild malaria patients) were genotyped for rs17860508 by PCR-direct sequencing.
RESULTS: The CTCTAA allele showed a significant association with susceptibility to cerebral malaria in the Thai population (allelic OR = 1.37; one sided P-value = 0.030).
CONCLUSIONS: The existence of a significant association between the CTCTAA allele and susceptibility to cerebral malaria was confirmed in Southeast Asian population, which was previously reported in African populations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20003322      PMCID: PMC2797809          DOI: 10.1186/1475-2875-8-290

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   2.979


  10 in total

Review 1.  Interleukin-12 and malaria.

Authors:  J M Crutcher; M M Stevenson; M Sedegah; S L Hoffman
Journal:  Res Immunol       Date:  1995 Sep-Oct

2.  Low interleukin-12 activity in severe Plasmodium falciparum malaria.

Authors:  A J Luty; D J Perkins; B Lell; R Schmidt-Ott; L G Lehman; D Luckner; B Greve; P Matousek; K Herbich; D Schmid; J B Weinberg; P G Kremsner
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 3.  Modulation of host responses to blood-stage malaria by interleukin-12: from therapy to adjuvant activity.

Authors:  M M Stevenson; Z Su; H Sam; K Mohan
Journal:  Microbes Infect       Date:  2001-01       Impact factor: 2.700

4.  Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity.

Authors:  D J Perkins; J B Weinberg; P G Kremsner
Journal:  J Infect Dis       Date:  2000-08-17       Impact factor: 5.226

5.  A promoter polymorphism in the gene encoding interleukin-12 p40 (IL12B) is associated with mortality from cerebral malaria and with reduced nitric oxide production.

Authors:  G Morahan; C S Boutlis; D Huang; A Pain; J R Saunders; M R Hobbs; D L Granger; J B Weinberg; N Peshu; E D Mwaikambo; K Marsh; D J Roberts; N M Anstey
Journal:  Genes Immun       Date:  2002-11       Impact factor: 2.676

6.  Association of IL12B promoter polymorphism with severity of atopic and non-atopic asthma in children.

Authors:  Grant Morahan; Dexing Huang; Mark Wu; Barbara J Holt; Gregory P White; Garth E Kendall; Peter D Sly; Patrick G Holt
Journal:  Lancet       Date:  2002-08-10       Impact factor: 79.321

7.  Deficient IL-12p70 secretion by dendritic cells based on IL12B promoter genotype.

Authors:  J Müller-Berghaus; K Kern; A Paschen; X D Nguyen; H Klüter; G Morahan; D Schadendorf
Journal:  Genes Immun       Date:  2004-08       Impact factor: 2.676

8.  A functional promoter variant in IL12B predisposes to cerebral malaria.

Authors:  Sandrine Marquet; Ogobara Doumbo; Sandrine Cabantous; Belco Poudiougou; Laurent Argiro; Innocent Safeukui; Salimata Konate; Sibiri Sissoko; Estelle Chevereau; Abdoulaye Traore; Mamadou M Keita; Christophe Chevillard; Laurent Abel; Alain J Dessein
Journal:  Hum Mol Genet       Date:  2008-04-15       Impact factor: 6.150

9.  IL10 and IL12B polymorphisms each influence IL-12p70 secretion by dendritic cells in response to LPS.

Authors:  Judy C Peng; Sazaly Abu Bakar; Michelle M Richardson; Julie J Jonsson; Ian H Frazer; Lars K Nielsen; Grant Morahan; Ranjeny Thomas
Journal:  Immunol Cell Biol       Date:  2006-04       Impact factor: 5.126

10.  Therapy with a combination of low doses of interleukin 12 and chloroquine completely cures blood-stage malaria, prevents severe anemia, and induces immunity to reinfection.

Authors:  K Mohan; H Sam; M M Stevenson
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

  10 in total
  4 in total

1.  Analysis of gene expression profiles to study malaria vaccine dose efficacy and immune response modulation.

Authors:  Supantha Dey; Harpreet Kaur; Mohit Mazumder; Elia Brodsky
Journal:  Genomics Inform       Date:  2022-09-30

2.  Cord Blood IL-12 Confers Protection to Clinical Malaria in Early Childhood Life.

Authors:  Yong Song; Ruth Aguilar; Jing Guo; Maria Nelia Manaca; Augusto Nhabomba; Tamara Katherine Berthoud; Siew-Kim Khoo; Selma Wiertsema; Arnoldo Barbosa; Llorenç Quintó; Ingrid A Laing; Alfredo Mayor; Caterina Guinovart; Pedro L Alonso; Peter N LeSouëf; Carlota Dobaño; Guicheng Brad Zhang
Journal:  Sci Rep       Date:  2018-07-18       Impact factor: 4.379

3.  The host genetic diversity in malaria infection.

Authors:  Vitor R R de Mendonça; Marilda Souza Goncalves; Manoel Barral-Netto
Journal:  J Trop Med       Date:  2012-12-13

4.  A Functional Polymorphism in the Promoter Region of Interleukin-12B Increases the Risk of Colorectal Cancer.

Authors:  Yabin Liu; Binghui Li; Lili Wang; Dexian Kong
Journal:  Biomed Res Int       Date:  2020-02-21       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.